Company profile
Global Hemp Group Inc.
OTC: GBHPF · Healthcare · Drug Manufacturers - Specialty & Generic
Canadian filerHQ North Vancouver, BCReports USD
#1161 of 1,418 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 33
v0.1 · 5/100 weight · pillars only
↑ listing tenure, disclosure history · ↓ 3-yr revenue growth, return on assets
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$1.9M
Employees
18
as of 2026-08-30
Market cap
$2.4k
as of 2026-08-30
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$00 CAD2023
Net income-$1.9M-2.6M CAD2023
Operating income-$412.3k-556.0k CAD2023
Total assets$31.6k42.8k CAD2023
Liabilities$4.3M5.8M CAD2023
Equity-$4.3M-5.8M CAD2023
Revenue trend
FY2017 – FY2023 · USD
FY17
FY18
FY19
FY20
FY21
FY22
FY23
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Global Hemp Group Inc.’s revenue?
Global Hemp Group Inc. booked $0 in FY2023 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.
Peers · Healthcare
Claritas Pharmaceuticals, Inc.——Sienna Biopharmaceuticals, Inc.——eFFECTOR Therapeutics, Inc.——OncoVista Innovative Therapies, Inc.——Regnum Corp.——Cotinga Pharmaceuticals Inc.——Key facts
CEOCurtis Ralph William Huber
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersNorth Vancouver, BC
ExchangeOTC: GBHPF
Employees18
IPO date2014-04-22
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.